| Primary |
| Osteoporosis |
48.6% |
| Osteopenia |
18.1% |
| Urinary Tract Infection |
5.6% |
| Bone Density Decreased |
4.2% |
| Bone Disorder |
4.2% |
| Bone Loss |
4.2% |
| Osteoporosis Postmenopausal |
2.8% |
| Prophylaxis |
2.8% |
| Bone Density Abnormal |
1.4% |
| Bone Scan |
1.4% |
| Diabetes Mellitus |
1.4% |
| Fracture |
1.4% |
| Menopause |
1.4% |
| Osteoporosis Prophylaxis |
1.4% |
| Stress Fracture |
1.4% |
|
| Vomiting |
13.9% |
| Musculoskeletal Pain |
8.3% |
| Pyrexia |
8.3% |
| Abdominal Pain |
5.6% |
| Arthralgia |
5.6% |
| Chest Pain |
5.6% |
| Dyspepsia |
5.6% |
| Femur Fracture |
5.6% |
| Influenza Like Illness |
5.6% |
| Nausea |
5.6% |
| Pain |
5.6% |
| Abdominal Pain Upper |
2.8% |
| Asthenia |
2.8% |
| Autonomic Neuropathy |
2.8% |
| Balance Disorder |
2.8% |
| Blood Calcium Decreased |
2.8% |
| Bone Pain |
2.8% |
| Bursitis |
2.8% |
| Diarrhoea |
2.8% |
| Drug Dose Omission |
2.8% |
|
| Secondary |
| Osteoporosis |
55.6% |
| Chronic Myeloid Leukaemia |
11.1% |
| Depression |
11.1% |
| Hepatic Function Abnormal |
11.1% |
| Pain |
11.1% |
|
| Drug Hypersensitivity |
25.0% |
| Drug Ineffective |
25.0% |
| Adverse Event |
8.3% |
| Joint Swelling |
8.3% |
| Loss Of Consciousness |
8.3% |
| Pruritus Generalised |
8.3% |
| Pyrexia |
8.3% |
| Weight Decreased |
8.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
34.0% |
| Rheumatoid Arthritis |
27.4% |
| Osteoporosis |
5.4% |
| Vitamin Supplementation |
4.3% |
| Hypertension |
3.1% |
| Gastrooesophageal Reflux Disease |
2.6% |
| Laryngospasm |
2.6% |
| Supplementation Therapy |
2.6% |
| Atrial Fibrillation |
2.0% |
| Drug Use For Unknown Indication |
2.0% |
| Chronic Obstructive Pulmonary Disease |
1.7% |
| Depression |
1.7% |
| Diabetes Mellitus |
1.7% |
| Type 2 Diabetes Mellitus |
1.7% |
| Bone Disorder |
1.4% |
| Anxiety |
1.1% |
| Emphysema |
1.1% |
| Hypothyroidism |
1.1% |
| Interstitial Lung Disease |
1.1% |
| Multiple Sclerosis |
1.1% |
|
| Laryngospasm |
23.7% |
| Weight Decreased |
10.5% |
| Fatigue |
7.9% |
| Pruritus |
7.9% |
| Constipation |
5.3% |
| Injection Site Pain |
5.3% |
| Vomiting |
5.3% |
| Anaphylactic Reaction |
2.6% |
| Arteriosclerosis |
2.6% |
| Calcium Deficiency |
2.6% |
| Cardiac Disorder |
2.6% |
| Cataract |
2.6% |
| Chills |
2.6% |
| Death |
2.6% |
| Diarrhoea |
2.6% |
| Drug Hypersensitivity |
2.6% |
| Dyspepsia |
2.6% |
| Dyspnoea |
2.6% |
| Dysuria |
2.6% |
| Exfoliative Rash |
2.6% |
|
